Madeline Barott, MD | |
236 Highland Ave, Somerville, MA 02143-1495 | |
(617) 591-4949 | |
(617) 591-4990 |
Full Name | Madeline Barott |
---|---|
Gender | Female |
Speciality | Ophthalmology |
Experience | 44 Years |
Location | 236 Highland Ave, Somerville, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508930587 | NPI | - | NPPES |
3008410 | Medicaid | MA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 47954 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Cambridge Health Alliance | Cambridge, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cambridge Public Health Commission | 8921910894 | 536 |
News Archive
In a large, international, randomized trial, initial radiotherapy was compared to temozolomide chemotherapy. A statistically significant difference between the two treatment strategies was not observed for progression-free survival, although radiotherapy was numerically favored. However, molecular tumor characterization may allow the treatment approach to be personalized and one or the other treatment modality to be selected.
New research published in The Lancet Respiratory Medicine and presented at this year's European Respiratory Society meeting in Amsterdam presents the first analyses of genetic data from the UK Biobank that reveal new associations with lung disease and smoking behaviour.
Helix BioMedix, Inc. (OTCBB: HXBM), a developer of bioactive peptides, today announced the United States Patent and Trademark Office has allowed multiple claims in one of the company's recent patent applications. US patent application 12/005653, "Short Bioactive Peptides for Cellular and Immunological Modulation," covers a number of peptides including Heptapeptide-7, a SmartPeptides™ technology and lead component in the Striking™ Skin Care line. The patent is expected to issue shortly.
A study showing that infants under one year of age can accept heart transplants from donors of different blood groups without the risk of organ rejection means a better chance of survival for infant patients and more efficient use of donor organs overall.
› Verified 4 days ago
Entity Name | Cambridge Public Health Commission |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932313228 PECOS PAC ID: 8921910894 Enrollment ID: O20050808000725 |
News Archive
In a large, international, randomized trial, initial radiotherapy was compared to temozolomide chemotherapy. A statistically significant difference between the two treatment strategies was not observed for progression-free survival, although radiotherapy was numerically favored. However, molecular tumor characterization may allow the treatment approach to be personalized and one or the other treatment modality to be selected.
New research published in The Lancet Respiratory Medicine and presented at this year's European Respiratory Society meeting in Amsterdam presents the first analyses of genetic data from the UK Biobank that reveal new associations with lung disease and smoking behaviour.
Helix BioMedix, Inc. (OTCBB: HXBM), a developer of bioactive peptides, today announced the United States Patent and Trademark Office has allowed multiple claims in one of the company's recent patent applications. US patent application 12/005653, "Short Bioactive Peptides for Cellular and Immunological Modulation," covers a number of peptides including Heptapeptide-7, a SmartPeptides™ technology and lead component in the Striking™ Skin Care line. The patent is expected to issue shortly.
A study showing that infants under one year of age can accept heart transplants from donors of different blood groups without the risk of organ rejection means a better chance of survival for infant patients and more efficient use of donor organs overall.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Madeline Barott, MD 236 Highland Ave, Somerville, MA 02143-1495 Ph: (617) 591-4949 | Madeline Barott, MD 236 Highland Ave, Somerville, MA 02143-1495 Ph: (617) 591-4949 |
News Archive
In a large, international, randomized trial, initial radiotherapy was compared to temozolomide chemotherapy. A statistically significant difference between the two treatment strategies was not observed for progression-free survival, although radiotherapy was numerically favored. However, molecular tumor characterization may allow the treatment approach to be personalized and one or the other treatment modality to be selected.
New research published in The Lancet Respiratory Medicine and presented at this year's European Respiratory Society meeting in Amsterdam presents the first analyses of genetic data from the UK Biobank that reveal new associations with lung disease and smoking behaviour.
Helix BioMedix, Inc. (OTCBB: HXBM), a developer of bioactive peptides, today announced the United States Patent and Trademark Office has allowed multiple claims in one of the company's recent patent applications. US patent application 12/005653, "Short Bioactive Peptides for Cellular and Immunological Modulation," covers a number of peptides including Heptapeptide-7, a SmartPeptides™ technology and lead component in the Striking™ Skin Care line. The patent is expected to issue shortly.
A study showing that infants under one year of age can accept heart transplants from donors of different blood groups without the risk of organ rejection means a better chance of survival for infant patients and more efficient use of donor organs overall.
› Verified 4 days ago
Dr. Savvas John Saragas, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 413 Highland Ave, Somerville, MA 02144 Phone: 617-623-1900 Fax: 617-623-1919 | |
Dr. Vincent J Patalano Ii, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 236 Highland Ave, Somerville, MA 02143 Phone: 617-665-4949 | |
Steven M Patalano, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 236 Highland Ave, Somerville, MA 02143 Phone: 617-665-1347 | |
Susan Wong, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 40 Holland St, Somerville, MA 02144 Phone: 617-629-6280 Fax: 617-629-6275 | |
Edward F Goodman, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 265 Medford St Ste 312, Somerville, MA 02143 Phone: 617-625-8250 Fax: 617-625-0718 | |
Ms. Rebecca Staphanie Hunter, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 40 Holland St, Somerville, MA 02144 Phone: 617-629-6280 |